A clinical trial to compare the effect between triamcinolone with hyaluronidase injection and triamcinolone injection alone in keloid patients

Use of intralesional injection of triamcinolone with hyaluronidase and triamcinolone alone in treatment of keloid:a comparative study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/07/014892

Enrollment

Registered

2018-07-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Keloid

Interventions

Intervention1: Intralesional Triamcinolone with Hyaluronidase injection: Intralesional injection of Triamcinolone (40 mg/ml)with Hyaluronidase (1500 IU/ml)(1:1 ratio) 1 ml to be injected in every 3 w

Eligibility

Inclusion criteria

Inclusion criteria: Keloid lesion of size 2-5 cm

Exclusion criteria

Exclusion criteria: Patients having allergy to Hyaluronidase or Triamcinolone, Pregnant patients,Patients with ITP, patients with secondary infection in and around keloid.

Design outcomes

Primary

Measure	Time frame
Reduction in pigmentation,vascularity,pliability,scar heightTimepoint: 6,12,18,24 weeks	—

Secondary

Measure	Time frame
Reduction in painTimepoint: 6,12,18,24 weeks;Reduction in pruritusTimepoint: 6,12,18,24 weeks	—

Countries

India

Contacts

Public ContactDr Prasanta Bhattacharya

Vivekananda Institute Of Medical Sciences

drprasanta.10@gmail.com09831046401

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026